(Q36673915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

review article

1 reference

title

Acutely dysregulated, chronically disabled by the enemy within: T-cell responses to HIV-1 infection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

0 references

Cynthia Mee Ling Munier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

author name string

A D Kelleher

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

publication date

5 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

Immunology & Cell Biology

22 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

volume

85

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

page(s)

6-15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.

22 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

Characterization of T lymphocyte responses during primary infection with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Peripheral blood mononuclear cell abnormalities and their relationship to clinical course in homosexual men with HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Effects of primary HIV-1 infection on subsets of CD4+ and CD8+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Increased losses of CD4+CD45RA+ cells in late stages of HIV infection is related to increased risk of death: evidence from a cohort of 347 HIV-infected individuals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Identification of a major co-receptor for primary isolates of HIV-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

A model of primary HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

T-cell-mediated immunopathology versus direct cytolysis by virus: implications for HIV and AIDS.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Immune reconstitution after highly active anti-retroviral treatment of HIV infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Restoration of the immune system with anti-retroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

CD4+ and CD8+ T cell receptor repertoire perturbations with normal levels of T cell receptor excision circles in HIV-infected, therapy-naive adolescents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Combination antiretroviral therapy results in a rapid increase in T cell receptor variable region beta repertoire diversity within CD45RA CD8 T cells in human immunodeficiency virus-infected children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

T cell expansions in lymph nodes and peripheral blood in HIV-1-infected individuals: effect of antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Longitudinal changes in CD4+ T cell antigen receptor diversity and naive/memory cell phenotype during 9 to 26 months of antiretroviral therapy of HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Relative significance of different pathways of immune reconstitution in HIV type 1 infection as estimated by mathematical modeling.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Naïve T Cells Are Maintained in the Periphery During the First3 Months of Acute HIV-1 Infection: Implications for Analysis of Thymus Function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV infection rapidly induces and maintains a substantial suppression of thymocyte proliferation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Changes in thymic function with age and during the treatment of HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Thymopoiesis in HIV-infected adults after highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Quantification of thymic function by measuring T cell receptor excision circles within peripheral blood and lymphoid tissues in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Identification of a human recent thymic emigrant phenotype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

IL-7 is critical for homeostatic proliferation and survival of naive T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Expression of CD31 epitopes on human lymphocytes: CD31 monoclonal antibodies differentiate between naive (CD45RA+) and memory (CD45RA-) CD4-positive T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Distinct Mechanisms of T Cell Reconstitution Can Be Identified by Estimating Thymic Volume in Adult HIV‐1 Disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Increased plasma interleukin-7 level correlates with decreased CD127 and Increased CD132 extracellular expression on T cell subsets in patients with HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Loss of IL-7Ralpha is associated with CD4 T-cell depletion, high interleukin-7 levels and CD28 down-regulation in HIV infected patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Loss of CD127 expression defines an expansion of effector CD8+ T cells in HIV-infected individuals.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Modulation of interleukin-7 receptor expression characterizes differentiation of CD8 T cells specific for HIV, EBV and CMV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Dysregulation of interleukin-7 receptor may generate loss of cytotoxic T cell response in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV-specific CD8 T cells express low levels of IL-7Ralpha: implications for HIV-specific T cell memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Cutting edge: emergence of CD127high functionally competent memory T cells is compromised by high viral loads and inadequate T cell help

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Kinetics of CD4+ T cell repopulation of lymphoid tissues after treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Programmed cell death in HIV infection: dysregulation of BCL-2 and Fas pathways and contribution to AIDS pathogenesis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Stimulated human lamina propria T cells manifest enhanced Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Functional expression of Fas and Fas ligand on human gut lamina propria T lymphocytes. A potential role for the acidic sphingomyelinase pathway in normal immunoregulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Nonproliferating bystander CD4+ T cells lacking activation markers support HIV replication during immune activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

CD4+ lymphocyte function with early human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. Independence of CD4+ cell numbers and clinical staging

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Interleukin-2 production used to detect antigenic peptide recognition by T-helper lymphocytes from asymptomatic HIV-seropositive individuals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Lymphoproliferative immune function in the Sydney Blood Bank Cohort, infected with natural nef/long terminal repeat mutants, and in other long-term survivors of transfusion-acquired HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Loss of CD4+ T cell proliferative ability but not loss of human immunodeficiency virus type 1 specificity equates with progression to disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Effects of sustained HIV-1 plasma viremia on HIV-1 Gag-specific CD4+ T cell maturation and function.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Central memory CD4+ T cell responses in chronic HIV infection are not restored by antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Changes in CD4+ T-cell differentiation phenotype during structured treatment interruption in patients with chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

CD127+CCR5+CD38+++ CD4+ Th1 effector cells are an early component of the primary immune response to vaccinia virus and precede development of interleukin-2+ memory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV preferentially infects HIV-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Elevated CD38 antigen expression on CD8+ T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the Multicenter AIDS Cohort Study than CD4+ cell count, soluble immune activation markers, or combinations of

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Cellular immune responses to HIV.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Skewed maturation of memory HIV-specific CD8 T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Restoring function in exhausted CD8 T cells during chronic viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Functional discrepancies in HIV-specific CD8+ T-lymphocyte populations are related to plasma virus load

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Frequency and function of HIV-specific CD8(+) T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Association of strong virus-specific CD4 T cell responses with efficient natural control of primary HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Antigenic oscillations and shifting immunodominance in HIV-1 infections.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Substantial differences in specificity of HIV-specific cytotoxic T cells in acute and chronic HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Evolution and transmission of stable CTL escape mutations in HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Immune restoration disease after antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Cytomegalovirus (CMV) Retinitis Immune Restoration Disease Occurs during Highly Active Antiretroviral Therapy–Induced Restoration of CMV‐Specific Immune Responses within a Predominant Th2 Cytokine Environment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Activation of thymic regeneration in mice and humans following androgen blockade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100015

7 January 2021

Identifiers

DOI

10.1038/SJ.ICB.7100015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17146463%20AND%20SRC:MED&resulttype=core&format=json

22 December 2019

1 reference